Respiratory bronchiolitis interstitial lung disease
ICD-10 J84.115 is a billable code used to indicate a diagnosis of respiratory bronchiolitis interstitial lung disease.
Respiratory bronchiolitis interstitial lung disease (RB-ILD) is a form of interstitial lung disease characterized by inflammation and scarring of the lung tissue, primarily affecting the bronchioles. Clinically, patients may present with symptoms such as chronic cough, dyspnea (shortness of breath), and fatigue. The disease is often associated with smoking, leading to a distinct pattern of respiratory symptoms and radiological findings. Anatomically, the condition involves the small airways and surrounding lung parenchyma, leading to impaired gas exchange and reduced lung function over time. Disease progression can vary, with some patients experiencing a gradual decline in pulmonary function, while others may have more rapid deterioration. Diagnostic considerations include high-resolution computed tomography (HRCT) scans, which typically reveal ground-glass opacities and reticular patterns, along with pulmonary function tests that demonstrate restrictive lung disease. A thorough clinical history, including smoking status and exposure to environmental toxins, is essential for accurate diagnosis and management.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J84.115 specifically covers respiratory bronchiolitis interstitial lung disease, which is primarily associated with smoking and characterized by bronchiolar inflammation and fibrosis. It is distinct from other interstitial lung diseases that may have different etiologies or clinical presentations.
J84.115 should be used when the clinical presentation aligns specifically with respiratory bronchiolitis interstitial lung disease, particularly in patients with a history of smoking. It is important to differentiate it from other interstitial lung diseases, such as J84.10, which is used for unspecified interstitial lung disease.
Documentation for J84.115 should include a detailed clinical history, evidence of smoking history, results from imaging studies (such as HRCT), and pulmonary function tests that indicate restrictive lung disease. Additionally, any treatment plans and responses should be documented.
